Skip to main content
Top
Published in: Archives of Virology 2/2018

01-02-2018 | Original Article

Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova

Authors: Ala Gori, Stela Gheorgita, Constantin Spinu, Iurie Pinzaru, Ala Halacu, Octavian Sajen, Luminița Suveica, Aurélie Sausy, Claude P. Muller, Judith M. Hübschen

Published in: Archives of Virology | Issue 2/2018

Login to get access

Abstract

In the Republic of Moldova, little is known about hepatitis B, C and D virus (HBV, HCV, HDV) genotypes, although the genetic variant may influence the course and outcome of disease. For HBV genotyping, 301 hepatitis B surface antigen (HBsAg)-positive sera collected in 2010 and 2011 from drug users, prison inmates, commercial sex workers, and the general population in different geographical regions were investigated. The 31 HBsAg-positive sera collected in 2011 were also tested for HDV. Eighty-eight anti-HCV-positive sera collected between 2010 and 2011 from the general population and health care workers were used for HCV genotyping. Phylogenetic analysis of 84 HBV sequences showed that most of the viruses belonged to genotype D (n = 82, 97.6%), predominantly to the subgenotype D1/D2 cluster (n = 75/82, 91.5%). One sequence (74110) clustered as an outlier to this cluster, and six sequences belonged to subgenotype D3. Only two subgenotype A2 sequences were found. Cloning of six samples with ambiguous sequence chromatogram signals showed no mixed infections. Phylogenetic analysis of HCV sequences from 66 patients showed a predominance of subtype 1b (n = 63, 95.5%). Two sequences belonged to subtype 3a, and one to subtype 2a. HDV RNA belonging to genotype 1 was found in two sera (2/31, 6.5%). Thus, genotypes prevalent in Europe were detected for all three hepatitis viruses. For both HBV and HCV, one genotype was dominant, while occasional other variants seem to be restricted to certain cohorts and/or transmission routes.
Literature
7.
go back to reference Mayerat C, Mantegani A, Frei PC (1999) Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 6(4):299–304CrossRefPubMed Mayerat C, Mantegani A, Frei PC (1999) Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 6(4):299–304CrossRefPubMed
12.
go back to reference Guriev V, Spanu C, Isac M, Sajen O, Spinu I, Casaidi E (2013) Evolution of epidemical process of acute viral hepatitis B, C and D in the context of realization of National Programs for viral hepatitis B, C and D prevention. Romanian. National Center of Public Health, Chisinau, Republic of Moldova, Curierul Medical 56(5):172–176 Guriev V, Spanu C, Isac M, Sajen O, Spinu I, Casaidi E (2013) Evolution of epidemical process of acute viral hepatitis B, C and D in the context of realization of National Programs for viral hepatitis B, C and D prevention. Romanian. National Center of Public Health, Chisinau, Republic of Moldova, Curierul Medical 56(5):172–176
13.
go back to reference National Center of Public Health (2012) National Program for Control of Hepatitis B, C and D for the years 2012–2016. Romanian Official publication Nr 34-37, article Nr 115:1–20 National Center of Public Health (2012) National Program for Control of Hepatitis B, C and D for the years 2012–2016. Romanian Official publication Nr 34-37, article Nr 115:1–20
14.
go back to reference National Center of Public Health (2013) Epidemiological surveillance of viral hepatitis Romanian. Epidemiological state surveillance of public health in the Republic of Moldova. Natl Rep 2013:95–102 National Center of Public Health (2013) Epidemiological surveillance of viral hepatitis Romanian. Epidemiological state surveillance of public health in the Republic of Moldova. Natl Rep 2013:95–102
16.
go back to reference Olinger CM, Venard V, Njayou M, Oyefolu AO, Maiga I, Kemp AJ, Omilabu SA, le Faou A, Muller CP (2006) Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. J Gen Virol 87(Pt 5):1163–1173. https://doi.org/10.1099/vir.0.81614-0 CrossRefPubMed Olinger CM, Venard V, Njayou M, Oyefolu AO, Maiga I, Kemp AJ, Omilabu SA, le Faou A, Muller CP (2006) Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. J Gen Virol 87(Pt 5):1163–1173. https://​doi.​org/​10.​1099/​vir.​0.​81614-0 CrossRefPubMed
20.
go back to reference Ho E, Deltenre P, Nkuize M, Delwaide J, Colle I, Michielsen P, Belgian Association for the Study of the L (2013) Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection. J Med Virol 85(9):1513–1517. https://doi.org/10.1002/jmv.23653 CrossRefPubMed Ho E, Deltenre P, Nkuize M, Delwaide J, Colle I, Michielsen P, Belgian Association for the Study of the L (2013) Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection. J Med Virol 85(9):1513–1517. https://​doi.​org/​10.​1002/​jmv.​23653 CrossRefPubMed
22.
go back to reference Yu X, Guo R, Ke S, Huang Q, Lin C, Lin Z, Chen S, Li J, Yang P, Su Z (2015) Changes in HBsAg titer and HBV DNA load and their correlation in patients with chronic hepatitis B and HBV-related liver cirrhosis Chinese. Nan fang yi ke da xue xue bao. J South Med Univ 35(5):682–686 Yu X, Guo R, Ke S, Huang Q, Lin C, Lin Z, Chen S, Li J, Yang P, Su Z (2015) Changes in HBsAg titer and HBV DNA load and their correlation in patients with chronic hepatitis B and HBV-related liver cirrhosis Chinese. Nan fang yi ke da xue xue bao. J South Med Univ 35(5):682–686
23.
go back to reference Constantinescu I, Nedelcu F, Toader MA, Daniela V (2008) Clinical and therapeutical importance of HBV genotyping in Romania. J Med Life 1(2):165–173PubMedPubMedCentral Constantinescu I, Nedelcu F, Toader MA, Daniela V (2008) Clinical and therapeutical importance of HBV genotyping in Romania. J Med Life 1(2):165–173PubMedPubMedCentral
24.
go back to reference Malyy VP, Lyadova TI, Boyko VV, Gololobova OV, Karazina VN (2011) Clinical significance of genotyping obligate hepatotropic viruses Russian. Clin Immunol Allergol Infectiol 6–7:48–53 Malyy VP, Lyadova TI, Boyko VV, Gololobova OV, Karazina VN (2011) Clinical significance of genotyping obligate hepatotropic viruses Russian. Clin Immunol Allergol Infectiol 6–7:48–53
26.
go back to reference Sultana C, Oprisan G, Szmal C, Vagu C, Temereanca A, Dinu S, Teleman MD, Ruta S (2011) Molecular epidemiology of hepatitis C virus strains from Romania. J Gastrointest Liver Dis 20(3):261–266 Sultana C, Oprisan G, Szmal C, Vagu C, Temereanca A, Dinu S, Teleman MD, Ruta S (2011) Molecular epidemiology of hepatitis C virus strains from Romania. J Gastrointest Liver Dis 20(3):261–266
30.
go back to reference Le Gal F, Badur S, Hawajri NA, Akyuz F, Kaymakoglu S, Brichler S, Zoulim F, Gordien E, Gault E, Deny P (2012) Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins. Arch Virol 157(4):647–659. https://doi.org/10.1007/s00705-011-1212-8 CrossRefPubMed Le Gal F, Badur S, Hawajri NA, Akyuz F, Kaymakoglu S, Brichler S, Zoulim F, Gordien E, Gault E, Deny P (2012) Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins. Arch Virol 157(4):647–659. https://​doi.​org/​10.​1007/​s00705-011-1212-8 CrossRefPubMed
32.
go back to reference Olinger CM, Lazouskaya NV, Eremin VF, Muller CP (2008) Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and Western European influences. Clin Microbiol Infect 14:575–581CrossRefPubMed Olinger CM, Lazouskaya NV, Eremin VF, Muller CP (2008) Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and Western European influences. Clin Microbiol Infect 14:575–581CrossRefPubMed
33.
go back to reference Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J (2003) Determining hepatitis C genotype by analyzing the sequence of the NS5B region. J Virol Methods 109:187–193CrossRefPubMed Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J (2003) Determining hepatitis C genotype by analyzing the sequence of the NS5B region. J Virol Methods 109:187–193CrossRefPubMed
Metadata
Title
Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova
Authors
Ala Gori
Stela Gheorgita
Constantin Spinu
Iurie Pinzaru
Ala Halacu
Octavian Sajen
Luminița Suveica
Aurélie Sausy
Claude P. Muller
Judith M. Hübschen
Publication date
01-02-2018
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 2/2018
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3632-6

Other articles of this Issue 2/2018

Archives of Virology 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.